TCGA prostate adenocarcinoma (PRAD) copy number gistic2 thresholded estimate

{"owner":"TCGA","longTitle":"TCGA prostate adenocarcinoma (PRAD) reverse phase protein array","cohort":"TCGA Prostate Cancer (PRAD)","url":"https://tcga-data.nci.nih.gov/tcgafiles/ftp_auth/distro_ftpusers/anonymous/tumor/prad/cgcc/mdanderson.org/mda_rppa_core/protein_exp/","dataSubType":"protein expression RPPA","security":"public","label":"RPPA","tags":["cancer"],"path":"data/public/TCGA/PRAD/RPPA","anatomical_origin":["Prostate"],"name":"TCGA.PRAD.sampleMap/RPPA","dataproducer":"MD Anderson Cancer Center TCGA proteome characterization center","wrangling_procedure":"Level_3 Data (file names: *.protein_expression.*) download from TCGA DCC, and processed at UCSC into Xena repository","sample_type":["tumor"],"redistribution":true,"domain":"TCGA","type":"genomicMatrix","wrangler":"Xena TCGAscript RPPA processed on 2017-09-08","version":"2017-09-08","unit":"normalized RPPA value","primary_disease":"prostate adenocarcinoma","platform":"M.D. Anderson Reverse Phase Protein Array Core platform","colnormalization":true,"description":"TCGA prostate adenocarcinoma (PRAD) protein expression by reverse phase protein array (RPPA).<br><br> The data was generated and processed at the MD Anderson Cancer Center TCGA proteome characterization center RPPA core. Level 3 interpreted level data was downloaded from TCGA data coordination center.<br><br>Data normalization from the MDACC RPPA core: <a href=\"http://bioinformatics.mdanderson.org/main/TCPA:Overview\" target=\"_blank\"><u>under section How are the RPPA data processed</u></a>.<br>"}

TCGA prostate adenocarcinoma (PRAD) reverse phase protein array

TCGA prostate adenocarcinoma (PRAD) segmented copy number

TCGA prostate adenocarcinoma (PRAD) exon expression by RNAseq (polyA+ IlluminaHiSeq)

{"cgdataversion":1,"owner":"TCGA","longTitle":"TCGA prostate adenocarcinoma (PRAD) PARADIGM inference activity (RNAseq)","cohort":"TCGA Prostate Cancer (PRAD)","url":"http://gdac.broadinstitute.org/runs/analyses__2016_01_28/data/PRAD/20160128/","probeMap":"paradigmPathwayV1.probeMap","dataSubType":"PARADIGM pathway activity","security":"public","label":"expression","tags":["cancer"],"path":"data/public/TCGA/PRAD/Pathway_Paradigm_RNASeq","anatomical_origin":["Prostate"],"name":"TCGA.PRAD.sampleMap/Pathway_Paradigm_RNASeq","dataproducer":"TCGA FIREHOSE pipeline","wrangling_procedure":"FIREHOSE data download from TCGA DCC, processed at UCSC into cgData repository","sample_type":["tumor"],"redistribution":true,"domain":"TCGA","groupTitle":"TCGA prostate adenocarcinoma","type":"genomicMatrix","wrangler":"cgData TCGAscript Pathway_Paradigm processed on 2017-09-08","version":"2017-09-08","primary_disease":"prostate adenocarcinoma","description":"Broad FireHose automated run results of TCGA prostate adenocarcinoma (PRAD) gene activity level inferred using the PARADIGM method on RNAseq data alone.<br><br>PARADIGM (PMID 20529912) is pathway analysis method to infer tumor sample-specific genetic activities by incorporating curated pathway interactions as well as integrating diverse types of genomic data. The pathways used in this analysis are from <a href=\"http://pid.nci.nih.gov/\" target=\"_blank\"><u>NCI pathway interaction database</u></a>.<br><br>"}